Ondine Biomedical (LON:OBI) announced the initiation of patient recruitment for an intensive care unit (ICU) pilot study at Royal Columbian Hospital (RCH) in New Westminster, British Columbia. The company states that...
Search results for - ondine
Ondine receives TAYYABA HASAN IMPACT AWARD at IPA World Congress
Ondine Biomedical (LON:OBI) was awarded the TAYYABA HASAN IMPACT AWARD at the 18th World Congress of International Photodynamic Association (IPA) in Finland for demonstrating “exceptional perseverance and clinical...
Ondine Biomedical names Simon Sinclair as CMO
Ondine Biomedical (LON:OBI) appointed Simon Sinclair, M.D., Ph.D., as chief medical officer, as the company prepares to start a U.S. Phase 3 trial of its nasal photodisinfection technology. Dr. Sinclair has more than 20...
Ondine presents effective photodisinfection treatment research against MRSA
Ondine Biomedical (LON:OBI) presented new research at the Infection Prevention Society Conference in Bournemouth, UK showing that its Steriwave photodisinfection technology is highly effective against clinical MRSA...
Ondine treats first patients in Phase 2 nasal photodisinfection trial
Ondine Biomedical (LON:OBI) treated the first patients in its nasal photodisinfection exploratory Phase 2 trial to evaluate how effectively the treatment eradicates pathogens – Staphylococcus aureus – in the nose, and...
Ondine Biomedical appoints renowned Prof Trevor Jones to lead COVID-19 advisory board
Ondine Biomedical (LSE:OBI), appointed Prof. Trevor Jones, CBE FMedSci, to lead a new advisory board on the use of its pioneering photodisinfection-based technology to prevent and treat COVID-19. Ondine’s non-antibiotic...
Ondine Biomedical names Cameron Lawrence as COO, CFO
Closely-held Ondine Biomedical appointed Cameron Lawrence as chief operating officer and chief financial officer.
